Everything listed here is Research Use Only (RUO). Not for human or animal consumption.
Metabolic & Weight Management · Fort Lauderdale, FL
Researchers in Fort Lauderdale and the broader Broward County corridor can obtain Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors that is investigated in metabolic-research models. Each Retatrutide vial with third-party COA verification is documented by ReVia for support reproducible laboratory work. Distributed for research use only.
A triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Studies have investigated its multi-receptor pharmacology and effects on metabolic signaling pathways.
Categorized among triple-agonist research peptides, retatrutide is studied in laboratory settings for how a single molecule engages multiple incretin-related receptors. Within Fort Lauderdale's wellness corridor and across Broward County, benchwork groups in Pompano Beach, Hollywood, and Plantation examine its receptor affinity and intracellular signaling in cultured systems, treating the peptide purely as a preclinical reference material for in-vitro characterization.
Retatrutide is worked with by researchers throughout the Fort Lauderdale metro — including Pompano Beach, Hollywood, Plantation, Coral Springs — and across Florida. Broward County's wellness corridor. Every ReVia-branded lot carries its own certificate of analysis, and the compound is intended strictly for research use.
Where do researchers in Fort Lauderdale research facilities obtain Retatrutide?
Retatrutide is supplied through i2b Health, ReVia's research partner, to researchers in Fort Lauderdale and surrounding Hollywood and Plantation labs for research use only. Transit times reflect standard carrier routes through Broward County.
Does Retatrutide come with a COA?
Each Retatrutide order includes a third-party Certificate of Analysis confirming compound identity and purity. Researchers may review the COA prior to study.
What is Retatrutide investigated for?
Retatrutide is investigated as a triple receptor agonist in weight-management and metabolic-health research at the laboratory level. It is supplied strictly for research and not for human consumption.
For research use only. Not for human or veterinary use. The information on this page is provided for educational and research purposes and does not constitute medical advice.